Targeting the Insulin-like Growth Factor Receptor-1R Pathway for Cancer TherapyJIPING ZHA; LACKNER, Mark R.Clinical cancer research (Print). 2010, Vol 16, Num 9, pp 2512-2517, issn 1078-0432, 6 p.Article

Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAF^V600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway SuppressionHOEFLICH, Klaus P; HERTER, Sylvia; STERN, Howard et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 7, pp 3042-3051, issn 0008-5472, 10 p.Article

Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non―Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and ErlotinibPUNNOOSE, Elizabeth A; ATWAL, Siminder; LACKNER, Mark R et al.Clinical cancer research (Print). 2012, Vol 18, Num 8, pp 2391-2401, issn 1078-0432, 11 p.Article

Predictive Biomarkers of Sensitivity to the Phosphatidylinositol 3' Kinase Inhibitor GDC-0941 in Breast Cancer Preclinical ModelsO'BRIEN, Carol; WALLIN, Jeffrey J; BEIVIN, Marcia et al.Clinical cancer research (Print). 2010, Vol 16, Num 14, pp 3670-3683, issn 1078-0432, 14 p.Article

Functional Genomics Identifies ABCC3 as a Mediator of Taxane Resistance in HER2-Amplified Breast CancerO'BRIEN, Carol; CAVET, Guy; LACKNER, Mark R et al.Cancer research (Baltimore). 2008, Vol 68, Num 13, pp 5380-5389, issn 0008-5472, 10 p.Article

High-Throughput Detection of Clinically Relevant Mutations in Archived Tumor Samples by Multiplexed PCR and Next-Generation SequencingBOURGON, Richard; SHAN LU; PATEL, Rajesh et al.Clinical cancer research (Print). 2014, Vol 20, Num 8, pp 2080-2091, issn 1078-0432, 12 p.Article

Phosphoinositide 3-Kinase (PI3K) Pathway Alterations Are Associated with Histologic Subtypes and Are Predictive of Sensitivity to PI3K Inhibitors in Lung Cancer Preclinical ModelsSPOERKE, Jill M; O'BRIEN, Carol; FRIEDMAN, Lori S et al.Clinical cancer research (Print). 2012, Vol 18, Num 24, pp 6771-6783, issn 1078-0432, 13 p.Article

In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer ModelsHOEFLICH, Klaus P; O'BRIEN, Carol; WEI ZHOU et al.Clinical cancer research (Print). 2009, Vol 15, Num 14, pp 4649-4664, issn 1078-0432, 16 p.Article

Evaluation and Clinical Analyses of Downstream Targets of the Akt Inhibitor GDC-0068YIBING YAN; SERRA, Violeta; WAGLE, Marie-Claire et al.Clinical cancer research (Print). 2013, Vol 19, Num 24, pp 6976-6986, issn 1078-0432, 11 p.Article